Is SARS ‐ CoV ‐2 Infection ( COVID ‐19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS ‐ CoV ‐2 Infection in Wales
Birth Defects Research · 2026-11 · 118 (11)
DOI: 10.1002/bdr2.70122 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Birth Defects Research, online erschienen am 30.10.2026. Verfasst von Samantha Rose Fisher und 4 weiteren Autor:innen. Beteiligte Einrichtung: Congenital Anomaly Register and Information Service, Public Health Wales, Cardiff, UK. Hauptthemen laut MEDLINE: Congenital Abnormalities, Pregnancy Complications, Infectious, COVID-19. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Explore the relationship between maternal SARS‐CoV‐2 infection and congenital anomalies in Wales. Study Design Mixed observational epidemiological cross‐sectional and cohort.
Methods
Congenital anomaly prevalence data were provided by the Congenital Anomaly Register and Information Service. Two comparisons were made using these data: firstly, congenital anomaly subgroup prevalence prior to and during the pandemic at population level, and in a cohort of women with laboratory‐confirmed maternal SARS‐CoV‐2 infection compared with the population trend.
Results
Prevalence of congenital anomalies in Wales was lower during the pandemic (mean 365 per 10,000 in 2020–22 vs. 454 per 10,000 in 2009–19) showing stable trends. However, the mean for abdominal wall defects increased from 9.8 per 10,000 births between 2009 and 2019 to 13.9 per 10,000 births in 2020–2022, largely attributed to an increase in omphalocele. A cohort of 486 confirmed maternal SARS‐CoV‐2 infections led to 181 births affected by congenital anomalies, and the trimester of infection did not impact the adjusted odds of this occurring. Circulatory anomalies were most frequently reported, consistent with pre‐pandemic population‐level data. Urinary and cardiac anomalies were more prevalent in this cohort group than at population level.
Conclusions
There was no clear evidence at population‐level of an association between congenital anomalies and maternal SARS‐CoV‐2 infection in Wales. However, a potential association with specific congenital anomalies cannot be excluded. Increased omphalocele is consistent with a Europe‐wide trend that pre‐dated COVID‐19. National surveillance registries should remain vigilant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Congenital Anomaly Register and Information Service, Public Health Wales, Cardiff, UK.
- Wales Gene Park, Cardiff University, Cardiff, UK.
- Swansea Bay University Health Board, Port Talbot, UK.
ORCID-Profile: Samantha Rose Fisher, David Tucker, Llion Davies
Zitieren
APA
Fisher, S. R., Maddison-Jarvis, R., Cresswell-Jones, P., Tucker, D., & Davies, L. (2026). Is SARS ‐ CoV ‐2 Infection ( COVID ‐19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS ‐ CoV ‐2 Infection in Wales. Birth Defects Research, 118(11). https://doi.org/10.1002/bdr2.70122
Vancouver
Fisher SR, Maddison-Jarvis R, Cresswell-Jones P, Tucker D, Davies L. Is SARS ‐ CoV ‐2 Infection ( COVID ‐19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS ‐ CoV ‐2 Infection in Wales. Birth Defects Research. 2026;118(11). doi:10.1002/bdr2.70122
BibTeX
@article{Fisher2026,
author = {Fisher, Samantha Rose and Maddison-Jarvis, Robert and Cresswell-Jones, Penelope and Tucker, David and Davies, Llion},
title = {Is SARS ‐ CoV ‐2 Infection ( COVID ‐19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS ‐ CoV ‐2 Infection in Wales},
journal = {Birth Defects Research},
year = {2026},
volume = {118},
number = {11},
doi = {10.1002/bdr2.70122}
}
EUVIMED